TennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71.

Latest action: Taken off notice for cal in s/c Tenncare Subcommittee of Insurance Committee

Voted 3/3/2026

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

Docket history

3/3/2026Taken off notice for cal in s/c Tenncare Subcommittee of Insurance Committee
2/25/2026Placed on s/c cal Tenncare Subcommittee for 3/3/2026
2/5/2026Assigned to s/c Tenncare Subcommittee
2/5/2026P2C, ref. to Insurance Committee
2/4/2026Sponsor change.
2/4/2026Intro., P1C.
2/3/2026Filed for introduction